郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxytryptamine 5HT(1A) receptors.

期刊：Bioorganic & medicinal chemistry letters发表年份：2012作者：Vladimir Sukalovic; Djurdjica Ignjatovic; Gordana Tovilovic; Deana Andric; Kaveh Shakib; Sladjana Kostic-Rajacic; Vukic Soskic
阅读更多 →

药效评价Ranking of multidimensional drug profiling data by fractional-adjusted bi-partitional scores.

期刊：Bioinformatics (Oxford, England)发表年份：2012作者：Dorit S Hochbaum; Chun-Nan Hsu; Yan T Yang
阅读更多 →

药效评价N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists.

期刊：Journal of medicinal chemistry发表年份：2012作者：Victor Hernandez-Olmos; Aliaa Abdelrahman; Ali El-Tayeb; Diana Freudendahl; Stephanie Weinhausen; Christa E Müller
阅读更多 →

药效评价Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.

期刊：FASEB journal : official publication of the Federation of American Societies for Experimental Biology发表年份：2012作者：Emilie Ceraudo; Régine Hierso; Yossan-Var Tan; Samuel Murail; Christiane Rouyer-Fessard; Pascal Nicole; Jean-Claude Robert; Nadège Jamin; Jean-Michel Neumann; Patrick Robberecht; Marc Laburthe; Alain Couvineau
阅读更多 →